HKUST Led Project Marks Hong Kong’s First Scientific Payload on the National Space Station
HONG KONG SAR – Media OutReach Newswire – 13 May 2026 – The world’s first lightweight, high‑resolution, high‑precision synergistic observatory for carbon dioxide (CO₂) and methane (CH₄) emission point sources – named “MUSICO”, Multi‑Spectral Imaging Carbon Observatory, led by The Hong Kong University of Science and Technology (HKUST) – was successfully launched aboard the Tianzhou‑10 cargo spacecraft on May 11 and has arrived at China’s Tiangong Space Station. This is not only Hong Kong’s first scientific payload deployed on the national space station, but also a historic breakthrough for the city in the development of high‑end aerospace instruments. The project fully demonstrates Hong Kong’s strong capability to build national‑level cutting-edge scientific payloads, to participate in long‑term space station missions, and to play a key role in addressing global climate change while serving the nation’s strategic “carbon peak and carbon neutrality” goals.
The project is led by an interdisciplinary research team from HKUST, comprising experts from the Department of Civil and Environmental Engineering, the Division of Emerging Interdisciplinary Areas, the Division of Environment and Sustainability, the Department of Computer Science and Engineering, and the Division of Public Policy. In late 2024, the project received formal approval from the Technology and Engineering Center for Space Utilization of the Chinese Academy of Sciences (CSU.CAS), the general research center for the Space Utilization System. It is jointly developed with the CAS Changchun Institute of Optics, Fine Mechanics and Physics, and funded by the Special Call (Aerospace Technology) of the Innovation and Technology Support Program under the Innovation and Technology Commission of the HKSAR Government.
MUSICO is a lightweight, high‑resolution, high‑precision greenhouse gas point‑source detection payload capable of accurately measuring CO₂ and CH₄ — two major greenhouse gases — from space. Smaller than a domestic washing machine, the instrument maintains extra-high spectral resolution and one hundred‑meter spatial resolution. By analyzing intensity changes of sunlight over specific spectral bands as it passes through the atmosphere and reflects off the Earth’s surface, MUSICO identifies gas‑specific absorption features to determine gas concentrations and pinpoint individual emission sources, enabling effective monitoring of key facilities such as power plants and landfills.
Prof. SUN Dong, Secretary for Innovation, Technology and Industry of the HKSAR Government, remarked, “This HKUST led project represents Hong Kong’s first scientific payload aboard the Tiangong Space Station, a major milestone for Hong Kong in the nation’s space missions. The national 15th Five Year Plan identifies accelerating green and low carbon transition, building a space powerhouse, and achieving carbon peak as key priorities. The successful deployment of a payload autonomously developed by a Hong Kong research team on Tiangong powerfully demonstrates that Hong Kong scientists possess top tier research and technology translation capabilities in frontier fields such as aerospace technology and green low carbon science, providing the nation with high quality, verifiable scientific data to accelerate the realization of the dual carbon goals.”
Prof. Nancy IP, President of HKUST, said, “We are deeply honored that our HKUST research team can participate in scientific missions on the national space station, and we sincerely thank the nation and the HKSAR Government for their long‑standing trust and support. This project not only highlights HKUST’s accumulated strengths in aerospace engineering, satellite remote sensing, and environmental engineering, but also proves that Hong Kong’s research capabilities can make substantial contributions on the nation’s highest‑level aerospace platforms. As the world’s first lightweight high‑precision greenhouse gas point‑source detection payload, MUSICO will continue to operate on the national space station, providing autonomous, controllable, high‑reliability CO₂ and CH₄ emission monitoring data that directly support the nation’s dual‑carbon goals and provide scientific backing for the ‘Beautiful China’ initiative and global climate governance.”
President Ip added, “In recent years, HKUST has been deepening its efforts in deep‑space exploration and low‑orbit satellite technology — following the successful launch of Hong Kong’s first higher‑education satellite in 2023, we are now actively participating in the nation’s Chang’e‑8 lunar exploration mission. Looking ahead, HKUST will continue to leverage its strengths in artificial intelligence, robotics, and materials science to accelerate the translation of space‑related technologies and nurture high‑end talent, contributing to the nation’s accelerated drive to build a space powerhouse and achieve green, low‑carbon, high‑quality development.”
Prof. SU Hui, Project Lead, Chair Professor of the Department of Civil and Environmental Engineering and Global STEM Professor at HKUST, said, “The development of MUSICO involved overcoming multiple critical technical challenges — namely, how to achieve high spectral resolution, fine spatial resolution, and synergistic multi‑gas observation under strict size and weight constraints. The team conducted extensive testing and optimization in optical design, precision manufacturing, and system integration to ensure the instrument can deliver reliable, accurate greenhouse gas data over long periods under high‑speed operation and extreme space environments. Successfully integrating these key technologies into a lightweight payload represents a landmark engineering and scientific achievement, demonstrating that the technology has reached internationally advanced standards.”
Prof. ZHANG Limin, Co‑Project Lead, National Engineer Awardee and Head of the Department of Civil and Environmental Engineering at HKUST, emphasized, “MUSICO’s observational coverage spans most land and ocean areas across low‑to‑mid‑latitude regions, providing consistent and comparable greenhouse gas monitoring data for different regions. The project’s results will be shared with government agencies and research institutions, supporting scientific research and practical applications in the Guangdong‑Hong Kong‑Macao Greater Bay Area and in other parts of China. They will also provide a scientific basis for cross‑regional climate research and emission reduction efforts along the Belt and Road, contributing to the global response to climate change. This is both a vivid example of HKUST’s research strength serving national strategy and a concrete practice of Hong Kong’s research capabilities contributing to global climate governance.”
The research project is co‑led by Prof. SU Hui, Chair Professor of the Department of Civil and Environmental Engineering and Global STEM Professor at HKUST, and Prof. ZHANG Limin, Chair Professor and Head of the same department. Prof. ZHAI Chengxing, Associate Professor of the Division of Emerging Interdisciplinary Areas serves as the mission system engineer. Other team members include: Senior Scientific Officer Dr. RONG Pingping, Prof. ZHANG Jize, and Prof. WANG Zhe from HKUST’s Department of Civil and Environmental Engineering; Prof. NING Zhi, Prof. SHI Xiaoming, and Prof. GU Dasa from the Division of Environment and Sustainability; Prof. MA Xiaojuan from the Department of Computer Science and Engineering; Prof. ZHU Pengyu from the Division of Public Policy; Prof. GAO Meng from Hong Kong Baptist University; and Prof. LI Jia from Lingnan University.
The project has also garnered strong industry support, including funding from HKUST-incubated startup Stellerus Technology Limited. Meanwhile, CLP Power Hong Kong Limited will collaborate with the project team to explore leveraging the data collected by MUSICO to complement its relevant assessments.
Hashtag: #HKUST
The issuer is solely responsible for the content of this announcement.
Set opposite Ben Thanh Market, One Central Saigon is a landmark mixed-use destination where luxury living, hospitality, retail and business converge at the centre of Ho Chi Minh City. The project also marks The Ritz-Carlton hotel brand’s debut in Vietnam, alongside The Ritz-Carlton Residences, Saigon, Grade A+ offices, curated retail, services and fine dining.
HO CHI MINH CITY, VIETNAM – Media OutReach Newswire – 13 May 2026 – Masterise Homes, a member of Masterise Group, has officially launched One Central Saigon, Vietnam’s first mixed-use landmark destination, marking the arrival of a new address where international standards of living, hospitality, retail, business and services come together in Ho Chi Minh City.
One Central Saigon brings together The Ritz-Carlton, Saigon, The Ritz-Carlton Residences, Saigon, Grade A+ offices, curated retail, dining and lifestyle experiences in central Ho Chi Minh City.
The launch event was attended by representatives of Ho Chi Minh City government authorities, senior leaders from Masterise Group, Masterise Homes and Marriott International, as well as leading experts in real estate, economics and tourism.
Over the past decade, the centre of gravity of the global economy has shifted decisively towards Asia, with Vietnam emerging as one of the region’s most compelling growth stories. Ho Chi Minh City, the country’s economic engine, is entering a new phase of development as a dynamic, deeply connected metropolis.
Around the world, certain developments have helped shape how cities are recognised internationally, from Hong Kong’s IFC and Singapore’s Marina Bay Sands to Kuala Lumpur’s Petronas Twin Towers and Dubai’s Burj Khalifa. These projects did more than create striking skylines. They helped shape how the world sees their cities and countries. One Central Saigon is positioned within this tradition of city-shaping developments, with a vision that combines international standards, Vietnamese identity and long-term urban value.
“We believe Vietnam has reached the moment where it is ready for a development of the calibre of One Central Saigon,” said Ms Nguyen Thi Minh Phuong, Managing Director, Southern Region, Masterise Group. “The project has been present in Ho Chi Minh City for some time and has passed through several phases of development. Today, it is being introduced with a clearer vision. With a sense of responsibility to contribute to the nation’s development journey in a new era, Masterise Group aspires to continue building an iconic landmark where the world’s highest experiential standards converge with the identity, energy and ambition of the city. This is also how we contribute to projecting the image of a modern, confident and culturally rich Vietnam onto the international stage.”
A rare address in the city’s historic core For more than a century, Ben Thanh Market has been one of Ho Chi Minh City’s great urban constants: a place of trade, arrival and encounter, and one of the few landmarks instantly recognised across Vietnam and beyond.
Its clock tower, market halls and surrounding streets are woven into the city’s daily rhythm and public memory, giving the area a significance that extends far beyond location. Set directly opposite the market, with four rare frontages along Pham Ngu Lao, Calmette, Le Thi Hong Gam and Pho Duc Chinh streets in the former District 1, One Central Saigon holds one of the city’s most strategic locations and shares a unique connection with Ho Chi Minh City’s historic urban core.
One Central Saigon will rise as two towers above a retail and commercial podium on an 8,537 sqm site, with 19,990 sqm of commercial space across seven above-ground levels and six basement floors. The retail centre is envisioned as a destination for luxury retail, curated services and fine dining, with brands and experiences selected for both international appeal and the evolving needs of Vietnamese customers. Its basement levels will connect directly to Ben Thanh Metro Station via an underground link, integrating the project with the city’s public transit network.
Together with Grade A+ offices, The Ritz-Carlton, Saigon and The Ritz-Carlton Residences, Saigon, the development forms a seamless mixed-use ecosystem for luxury living, hospitality, retail, business, services and lifestyle experiences at the centre of Ho Chi Minh City.
Song Long Ngậm Ngọc: Vietnamese symbolism, global expertise The architecture of One Central Saigon is inspired by Song Long Ngậm Ngọc, or Twin Dragons Playing with a Pearl, a Vietnamese cultural motif associated with strength, prosperity and wisdom. The two towers rise and converge around a central point, creating a contemporary architectural expression of Vietnamese identity within the Ben Thanh district.
Among the tallest twin towers in Vietnam and the region, One Central Saigon is a structurally complex undertaking that requires significant investment, precision, and attention at every stage of execution. The project brings together an international design and construction team, including Arquitectonica as design architect, HBA for interior design, B+H, a member of Surbana Jurong Group, as executive architect, and Turner for project management.
International operational standards add another defining layer of value to One Central Saigon. With more than a century of heritage in luxury hospitality, The Ritz-Carlton brings refinement, attention to detail, privacy and highly personalised service to the project’s ultra-luxury positioning.
The Ritz-Carlton Residences, Saigon opens a new chapter in ultra-luxury living, while The Ritz-Carlton, Saigon marks the hotel brand’s debut in Vietnam, reflecting Ho Chi Minh City’s growing appeal to international travellers, investors, entrepreneurs and high-net-worth individuals.
The Grade A+ office component is designed for global corporations and forward-thinking business leaders seeking a workplace within a 5-star international ecosystem. Vietnam’s luxury momentum accelerates The launch comes as Vietnam continues to attract global capital, international brands and a rising generation of high-net-worth consumers. Official data showed real GDP growth of 8.02% in 2025, up from 7.09%, while foreign direct investment reached a record US$27.62 billion.
Tourism is adding further momentum. Vietnam welcomed nearly 21.2 million international visitors in 2025, its strongest year for inbound tourism, while Ho Chi Minh City received nearly 8.6 million international visitors, up 40.3% year on year.
Branded residences are following the same trajectory. Savills reports that branded residences in Asia Pacific increased by 55% over the past five years, while C9 Hotelworks’ Asia Branded Residences Market Review 2025 points to Vietnam as one of the region’s most important future supply markets.
For Masterise Group, One Central Saigon extends an international branded real estate portfolio that includes Grand Marina, Saigon, featuring Marriott and JW Marriott-branded residences, and The Ritz-Carlton Residences, Hanoi at The Grand. It also gives Vietnam’s ultra-luxury real estate growth story tangible form beside one of Ho Chi Minh City’s most prized historical sites.
As the city enters a new phase of development, expanding in both scale and quality, thoughtfully planned and professionally operated integrated developments such as One Central Saigon are expected to enrich the city’s tourism, services and urban experience ecosystem. The project is positioned to create lasting value for the community and elevate the standing of Ho Chi Minh City and Vietnam on the international stage. Hashtag: #MasteriseGroup
The issuer is solely responsible for the content of this announcement.
About Masterise Group
Masterise Group is an international real estate development group, pioneering a comprehensive ecosystem spanning residential and hospitality developments, as well as urban infrastructure and logistics. Founded in 2007 as Thao Dien Investment and officially rebranded as Masterise Group in 2019, Masterise Group sees real estate as more than buildings; it is the foundation for a nation’s future, providing infrastructure for connection, momentum for progress, elevated living and generational legacy. With a long-term vision, Masterise Group continuously pushes boundaries, creates sustainable value, elevates quality of life and contributes to strengthening Vietnam’s new era of growth and global ambition.
Masterise Homes is a member of Masterise Group and manages and develops all of the group’s residential real estate brands. As Vietnam’s pioneer in branded real estate development, Masterise Homes’ mission goes beyond delivering architectural landmarks with refined design and integrated amenities. Masterise Homes strives to craft comprehensive living spaces where residents experience a standard of living that goes beyond the basic function of a home.
旗下晨暉生技董事會通過以100%股權收購Weider Global Nutrition（「WGN」）；該品牌公司總部設於美國鳳凰城，為全球指標性運動營養品牌，與美國大賣場Costco具策略性供應商關係，業務遍及60餘國，並有Amazon、Walmart等穩定銷售據點。本案除了挹注集團事業規模，CDMO、全球市場銷售、保健品三大事業也完成最後一塊拼圖。
CDMO業務方面，2026年是策略性投資開啟新篇章的關鍵年。第一季我們完成回應特定的客戶需求面向的組織與服務升級。我們在CDMO事業體內成立MSAT（Manufacturing, Science and Technology）團隊作為研發核心，深化全客戶層級的科學與技術能力；保瑞相信此一能力於現階段至關重要：在募資環境逐步回溫但仍受限的氛圍下，中小型生技與製藥客戶受在地化製造政策推動需重新檢視供應鏈布局。同時，我們將企業客戶管理團隊優化為網絡式架構，滿足近距離支援客戶的需求。上述布局精準切入客戶痛點，使保瑞具備在動盪的政經環境中開創新一波商業動能的能力。
Transformational Acquisitions Expected to Contribute to Long Term Growth Starting 2Q26
HONG KONG SAR – Media OutReach Newswire – 13 May 2026 – Bora Pharmaceuticals (“Bora”; TWSE: 6472; OTCQX: BORAY) today announced its financial results and operational highlights for 1Q2026 and provides full year outlook.
1Q26 Business and Financial Highlights
The Company reported 1Q26 revenues of NT$4,001 million, down 17.68% sequentially, with basic EPS of NT$0.21. Gross margin stabilized quarter-over-quarter. The quarter reflected temporary slowdown across both businesses: pricing and demand variability in the generics market through January and February left Upsher-Smith’s 1Q26 revenue 18.63% below the trailing four-quarter run rate, while the scheduled annual maintenance of 6 weeks of our Maryland fill-finish facility limited fixed-cost absorption during the quarter, weighed on earnings quality.
March saw a rebound in both businesses as conditions improved for both the top and bottom lines with steady demand. During the quarter, the Company advanced Maple Grove site ramp-up significantly, with several multi-year CDMO agreements signed or progressing across pharma clients of various sizes. Additionally, the Company continues to win new CDMO business as 12-month rolling backlog arrived at US$315 million. With a healthy order book at North American sites entering the second quarter, we expect fixed-cost leverage to resume, driving profit improvement as utilization builds across the installed asset base. Meanwhile, Upsher-Smith has successfully defended market share and is deploying lifecycle management initiatives that reinforce our ability to set the cadence of sales in a dynamic competitive environment.
Non-operating loss primarily reflected a wider equity loss from affiliate Tanvex Biopharma, together with higher tax expense driven by annual 1Q recognition of tax from undistributed earnings of the previous year.
Disciplined OPEX control has driven expenses down 14.87% quarter-over-quarter and 14.41% year-over-year. This signals that resources have settled in as we begin to see advantages in scale; The Company expects ROA and ROIC to trend gradually upward, albeit with some quarter-to-quarter variability as operating leverage builds.
Board of Directors approved the acquisition of the CDMO business of MacroGenics Inc. (NASDAQ: MGNX), for total consideration of US$122.5 million, leading to a total 12-month rolling backlog upon closing to approximately US$375 million.
Sunway Biotech’s Board approved the 100% acquisition of Weider Global Nutrition (“WGN”), an iconic Phoenix-based American sports nutrition brand with a strategic Costco U.S. supplier relationship, commercial presence in 60+ countries, and established positions on Amazon and Walmart. The transaction completes Bora Group’s three-platform architecture, namely CDMO, pharma sales, and nutraceuticals operated under our “dual engine” strategy.
Share capital increased 0.04% during the quarter from employee stock option exercise.
Mr. Bobby Sheng, Chairman of Bora Group, stated, “The beginning of 2026 was eventful and challenging both in the world and at Bora. We have seen supply chain disruptions, inflation from wars, and continuous geopolitical tensions. Yet through it all, Bora Group’s disciplined approach to growth-oriented investment remained unwavering.
Our CDMO business CAPEX-to-revenue ratio reached an all-time high of over 10% in 2025, marking another year of upward progression and bringing the Company to a level comparable with established global CDMO peers. This marked a deliberate shift in where we direct investments from capacity-led expansion that defined our earlier growth chapters to a sharper focus on capability demands and modality, anchored in innovation and technology. Over the past 18 months, we have pursued an ambitious growth trajectory against a dynamic macroeconomic backdrop – recalibrating expectations, sharpening our strategy, and reaffirming long-term plans. The underlying demand environment supports our conviction: global pharma is growing at 5-8% per year, biologics CDMO outsourcing demand at 15%+ and small-molecule outsourcing demand at 8-10%. With our investment foundation now in place, we believe our CDMO business is positioned to compound organically at 13-23% annually.
In the first quarter, we executed a series of organizational adjustments, each aligned to a specific dimension of customer demand. We established the MSAT (Manufacturing, Science and Technology) function within the CDMO business, the R&D backbone of the platform, to deepen scientific and technical capability across our entire client base, an increasingly critical asset as small and mid-sized biotech and pharma clients rethink their supply chain. In parallel, we repurposed the Strategic Enterprise Account Management team into a networked model to serve clients for whom customer proximity is paramount. Together, these capability investments target specific customer pain points and position Bora to navigate the evolving political and economic landscape and capture a new chapter of commercial momentum.
To sum up, CDMO business in 1Q26 delivered US$27.2 million in total external wins on top of orders on hand, 60% or 7 molecules from pre-commercial programs. For context, full-year 2025 saw 16 pre-commercial molecule signings; 1Q26 alone has already secured nearly half that count in a single quarter. This run-rate acceleration is a leading indicator: as our capability investments take hold, forward visibility and growth potential are set to compound. Bora’s CDMO business has entered a new phase. Reinforcing this trajectory, the Group’s recently announced acquisition of MacroGenics’ Rockville, Maryland CDMO facility adds a substantial commercial-stage monoclonal antibody programs backlog and manufacturing expertise to the Group. Equipped with five 2,000-liter and two 500-liter single-use bioreactors and integrated QC and analytical labs and currently generating more than half of revenues from commercial manufacturing, the transaction marks a pivotal step in scaling Bora’s integrated biologics CDMO platform, known as Bora Biologics. DS and DP capabilities shall be integrated over the next 12–18 months to offer global biotech customers a single partner from development through commercial supply in the U.S..
On the pharma sales side, the Group faced competition across a handful of core generic products. Upsher-Smith is navigating the competitive landscape with a clear focus on the most margin-accretive opportunities while continuing to scout niche, brand-oriented assets. Near-term, DLS market share has been defended; over the medium term, sustained market share maximization of the infantile spasm franchise coupled with swift pipeline replenishment weighted toward differentiated assets is critical. In the first quarter, we saw unique patients for VIGAFYDE grew by more than 140% over same period last year and a continuous increase in new patients. Both healthy signs of steady execution pace building up to durable resilience in the pharma sales business.” 1Q26 Operational Achievements & 2026 Outlook Global CDMO Operations
Revenues declined 24.62% year-over-year and 30.15% quarter-over-quarter including internal orders, mainly due to above-mentioned maintenance at fill and finish facility in Maryland, a routine cycle factored into our operating plan, and seasonality at Canada site. To scale biologics CDMO one-stop-shop platform in commercialized projects with SUB (Single Use Bioreactors) in the US; Board of Directors approved the acquisition of Rockville, Maryland based drug substance facility from MacroGenics for US$122.5 million.
Following closing, Bora Group intends to leverage the Rockville Site in cooperation with Tanvex Biopharma (TWSE: 6541), which operates the Group’s biologics CDMO franchise under the “Bora Biologics” brand. Together with Bora’s sterile drug product capabilities, this is expected to expand and strengthen the Group’s end-to-end biologics platform. The Rockville facility has operated as an outsource manufacturing partner since 2022 and is equipped with five 2,000-liter and two 500-liter single-use bioreactors and fully integrated QC and analytical laboratories and has been inspected by both the U.S. FDA and Japan’s PMDA.
During the quarter, 0.44 billion doses, or 108 molecules, were developed and manufactured. Excluding internal orders, the business accounted for 37.73% of consolidated revenues. Contribution from the top 20 global pharmaceutical companies stood at 32.10%.
As the Company continues to expand its CDMO capacity and capabilities, this year’s CAPEX plan is closely linked to the contracting cadence of a key customer anchored at Bora’s North American CDMO network. The Group expects to complete Maple Grove’s capital expenditure program in the first half of the year, sequencing the investment to grow in step with major pharmaceutical partners’ supply chain plans and optimize return on capital deployed.
Pharma Sales Operations
Discontinued operations impact in 2025 has materially abated this quarter, positioning Upsher-Smith to re-accelerate organic growth in 2026. Management has defined two strategic priorities for 2026, designed to enhance capital efficiency and sharpen commercial focus:
First, R&D capital allocation optimization. 505(b)(2) Pipeline programs have been transferred to Salus Therapeutics, an equity-method affiliate. Under this structure, Upsher-Smith retains the right to economic participation in commercial outcomes while shareholders’ exposure to early-stage development and regulatory risks, and associated cash burden is meaningfully reduced. The decision is consistent with the Group’s capital discipline observed across businesses.
Second, institutionalizing pipeline expansion capabilities. An integrated business development and medical affairs function is being established to systematically evaluate in-licensing, co-promotion, and bolt-on opportunities. This integrates Bora’s proven asset-selection and M&A strategy directly into Upsher-Smith’s commercial infrastructure, enabling franchise compounding through targeted external sourcing rather than capital-intensive internal development. These lifecycle initiatives focus but are not limited to pediatric epilepsy opportunities.
Collectively, Management expects Upsher-Smith to evolve fully into a capital efficient, commercially led, and therapeutically centered vehicle designed to deliver sustained shareholder value before exiting 2026.
Recent Investor Conference
Bora will host English online earnings call at 7:30 a.m. Taiwan time on May. 14th, 2026. The event will cover the Company’s 1Q26 financial and business results and 2026 outlook.
Bora will participate in 2026 Yuanta Securities Investment Forum in June. For 1:1 meetings with management, please contact your Yuanta representative.
Bora 2026 Earnings Schedule
Q2 2026: Expected in the 2nd week of Aug 2026 Q3 2026: Expected in the 2nd week of Nov 2026 Q4 2026: Expected in the 2nd week of Mar 2027
Hashtag: #BoraPharmaceuticals
The issuer is solely responsible for the content of this announcement.
About Bora
Founded in 2007, Bora Pharmaceuticals (“Bora” or “the Company”, 6472.TW and BORAY.OTCQX) is a leading pharmaceutical services company with a vision and goal of “Contributing to Better Health All Over the World”. Operating under a “Dual Engine” model that integrates CDMO and commercial expertise, we empower pharmaceutical and biotech partners to optimize product development, accelerate launches, and scale supply to meet global patient needs. At the same time, we actively broaden R&D and sales infrastructure, focusing on niche and rare disease markets to improve patients’ quality of life.
By investing in talent, infrastructure, and biologics expansion, Bora continues to transform operations and achieve sustainable growth. Committed to making success “certain,” Bora sets new standards in the pharmaceutical and CDMO industries.
This document and the accompanying information may contain forward-looking statements. All statements regarding the company’s future business operations, potential events, and prospects (including but not limited to forecasts, targets, estimates, and operational plans) are considered forward-looking statements unless they refer to factual occurrences. Forward-looking statements are subject to various factors and uncertainties that may cause significant differences from actual results, including but not limited to price fluctuations, actual demand, exchange rate variations, market share, competitive conditions, changes in the legal, financial, and regulatory framework, international economic and financial market conditions, political risks, cost estimates, and other risks and variables beyond the company’s control. These forward-looking statements are based on current predictions and assessments, and the company disclaims any responsibility for future updates.
以《大龍鳳》為劇場 IP 案例，連接粉絲參與與娛樂資產代幣化應用，潛在項目儲備規模預計逾港幣20億元
香港 – Media OutReach Newswire – 2026年5月13日 – 毅盛金融科技（證券）有限公司（「Esperanza」或「公司」）欣然宣布，旗下管理的代幣化基金參與協辦天下一幕有限公司（「天下一幕」）旗下的香港本地劇場 IP 項目《大龍鳳》，雙方已就此簽署合作安排。天下一幕為天下一集團旗下子公司。是次合作標誌著 Esperanza 繼早前娛樂演出代幣化項目後，進一步將其合規金融科技方案延伸至香港劇場、文化 IP 及粉絲參與場景，持續探索文化娛樂資產於新金融模式下的商業價值與應用潛力。
天下一集團為香港具代表性的綜合影視娛樂企業，業務涵蓋電影、電視、製作、後期製作、藝人管理及相關娛樂產業服務。是次與天下一幕的合作，不僅反映 Esperanza 持續拓展文化娛樂資產代幣化應用場景，亦展示香港本地優質內容及 IP 項目在新金融模式下的更多發展可能。
BANGKOK, THAILAND – Media OutReach Newswire – 13 May 2026 – LGT continues to strengthen its leadership team in Thailand with the appointment of Anchalee Bunsongsikul as Chief Executive Officer of LGT Securities (Thailand) Limited (“LGT Thailand”). This senior management hire underlines the strategic importance of Thailand for LGT and reflects the firm’s commitment to further expanding its presence in the market.
Anchalee Bunsongsikul
With over three decades of leadership experience in international banking, including most recently as President and Chief Executive Officer, Thailand and Representative Offices for Standard Chartered Bank, Anchalee Bunsongsikul will further strengthen LGT’s senior management bench in Thailand. She brings extensive experience in corporate banking, financial markets and client coverage, as well as a deep understanding of the local client landscape.
Commenting on the appointment, Dr. Henri Leimer, Chief Executive Officer, LGT Private Banking Asia Pacific, said: “Thailand is an important market for us, one where we have built a strong market position through a consistent, relationship-led approach focused on serving Thai families and entrepreneurs.” Karn Karuhadej, Managing Director and Senior Market Adviser, added: “Anchalee brings extensive leadership experience, strong client relationships and deep market knowledge that will further strengthen our franchise in Thailand. We look forward to welcoming her to our team and working together to further develop our business in the region.”
The appointment will take effect on 15 May 2026. Upon joining LGT Thailand, Anchalee Bunsongsikul will also become a member of the Executive Board Asia Pacific of LGT Private Banking.
LGT has deep roots in Asia. Since opening its first representative office in Hong Kong in 1986, LGT has grown into a competitive regional private bank and wealth manager. In 2019, LGT launched its wealth management business in Thailand. Today, the Bangkok office comprises a strong team of experienced relationship managers and investment consultants who provide investment and wealth management services to Thai clients, complementing LGT’s private banking operations in Hong Kong and Singapore.
Across Asia Pacific, LGT has a presence in Hong Kong, Singapore, Thailand, Japan, Australia, India and the Middle East, and employs around 1800 people in the region. In 2025, LGT ranked as the sixth1 largest private bank in the region, with USD 164 billion in assets under management as of the end of 2025.
The issuer is solely responsible for the content of this announcement.
LGT in brief
LGT is a leading international private banking and asset management group that has been fully controlled by the Liechtenstein Princely Family for over 90 years. As at 31 December 2025, LGT managed assets of CHF 386.1 billion (USD 487.3 billion) for wealthy private individuals and institutional clients. LGT employs 6000 people who work out of more than 40 locations in Europe, Asia, the Americas, Australia and the Middle East. www.lgt.com.
Hong Kong theatre IP “The Big Big Day” anchors the next phase of fan participation and entertainment asset tokenization, with qualifying projects potential exceeding HK$2 billion in scale
HONG KONG SAR – Media OutReach Newswire – 13 May 2026 – Esperanza Fintech (Securities) Limited (“Esperanza” or the “Company“) is pleased to announce that a tokenized fund managed by the Company has participated in co-presenting The Big Big Day (《大龍鳳》), a Hong Kong theatre IP project produced by One Cool Stage Limited (“One Cool Stage“), a subsidiary of One Cool Group Limited. A cooperation arrangement to this effect has been signed by both parties. The collaboration marks a further extension of Esperanza’s regulated fintech solutions — building on its earlier tokenized live-entertainment offerings — into Hong Kong theatre, cultural IP, and fan-engagement scenarios, as the Company continues to explore the commercial value and applications of cultural and entertainment assets under new financing models.
One Cool Group Limited is one of Hong Kong’s most recognizable integrated film and entertainment enterprises, with operations spanning film, television, production, post-production, artist management, and related entertainment services. The partnership with One Cool Stage not only reflects Esperanza’s continued expansion of tokenization use cases for cultural and entertainment assets, but also showcases the broader development potential of high-quality Hong Kong content and IP under new financing frameworks.
As a Hong Kong-based fintech and real-world asset (RWA) tokenization platform serving the Asia-Pacific market, Esperanza is committed to operating within a regulated framework to connect quality assets, professional investors, content owners, project operators, and fan communities — building more transparent, participative, and scalable financial infrastructure for cultural and entertainment projects.
Mr. Ronald Leung, Group Chief Executive Officer and Chief Legal Officer of Esperanza, said:
“The Big Big Day project is more than a single theatre collaboration — it represents another important milestone in Esperanza’s work to bring tokenized capital solutions to Hong Kong’s cultural and entertainment assets. Hong Kong has long stood at the intersection of Asian culture, creativity, and capital. We see this city as the ideal starting point for combining high-quality local content with next-generation fintech infrastructure, and for forging deeper value linkages among content owners, project parties, fan communities, and professional investors. As part of this project, Esperanza will also take the lead in launching tokenized experience applications in Hong Kong, enabling supporters to participate in ticket redemption, exclusive merchandise offerings, and cultural entertainment experiences through relevant tokenized arrangements. This will further extend the interaction between stage productions and audiences beyond the performance itself. Through compliant tokenization solutions, Esperanza will continue to support more projects of cultural significance and market potential in establishing financing connections that are more flexible, more transparent, and more participatory.”
Ms. Ella Wong, Chief Financial Officer of One Cool Group Limited, said:
“We are delighted to begin this collaboration with Esperanza. In today’s diversified entertainment ecosystem, innovation in financial structuring is critical to advancing the creative industries. Through this partnership, we look forward to leveraging professional fintech infrastructure and solutions to open up more flexible commercial possibilities for Hong Kong’s cultural and entertainment assets.”
This collaboration also reflects Esperanza’s continued strategic build-out in entertainment and cultural assets. The Company is actively sourcing additional projects with tokenization potential and commercial scalability — across film, live entertainment, theatre IP, licensing businesses, AI-driven immersive entertainment, multimedia applications, experiential venues, and other categories underpinned by real-asset foundations and commercial cash flow potential.
As Asia-Pacific’s content industries, fan-engagement models, AI technologies, and immersive entertainment ecosystems continue to evolve rapidly, Esperanza expects growing market demand for mature, compliant financial platforms capable of helping high-quality cultural and entertainment projects expand their access to capital, community engagement, and commercialization capabilities. The Company is currently evaluating and progressing multiple related opportunities, with a potential project pipeline expected to exceed HK$2 billion in scale across entertainment and culture, IP licensing, real estate, multimedia, AI immersive entertainment, and other real-world asset applications.
Esperanza emphasizes that the Company will continue to anchor its work in compliance, transparency, and sustainability — guiding cultural and entertainment assets from traditional project financing and single-consumption models toward more institutionalized, digitalized, and participatory new financing markets, and creating new growth opportunities for Hong Kong and the wider Asia-Pacific creative industries.
Hashtag: #Esperanza
The issuer is solely responsible for the content of this announcement.
About Esperanza Fintech (Securities) Limited
Esperanza Fintech (Securities) Limited (“Esperanza“) is a licensed corporation under the Securities and Futures Ordinance (Cap. 571 of the Laws of Hong Kong), permitted to carry on Type 4 (advising on securities) and Type 9 (asset management) regulated activities. On 13 February 2026, Esperanza received a “no further comment” letter from the Hong Kong Securities and Futures Commission in respect of its proposal to tokenize managed funds — formally permitting Esperanza to conduct tokenized investment business.
About One Cool Stage Limited
One Cool Stage Limited (“One Cool Stage“) is a subsidiary of One Cool Group Limited, engaged in the development of cultural, entertainment, and theatre projects in Hong Kong. Founded in 2013 and headquartered in Hong Kong, One Cool Group Limited is a diversified enterprise dedicated to the development of the film and entertainment industry. Guided by the philosophy of “Visionary in Creativity, Strive for Diversity,” the Group has built a multi-faceted business portfolio spanning the entire entertainment industry value chain, with stable partnerships and operational footprints across major Asian markets. For more information, please visit www.onecool.com.
About Esperanza Fintech Group
Esperanza Fintech Group is a fintech group headquartered in Hong Kong. The group’s licensed businesses include (i) gold trading and tokenized gold services operated by Esperanza Fintech (Commodities) Limited, a DPMS (dealers in precious metals and stones) Category A Registrant (No. A-B-25-03-08913) with the Hong Kong Customs with permitted businesses including the issuance, redemption and trading of gold backed instruments on www.espetopia.com; (ii) client asset custodian service operated by Esperanza Fintech (Nominees) Limited, a licensed Trust or Company Service Provider in Hong Kong (Licence No. TC010260), regulated by the Hong Kong Companies Registry; (iii) espetopia trading platform operated by Espetopia Limited; and (iv) tokenized investment services operated by affiliate company Esperanza Fintech (Securities) Limited, an SFC-regulated asset manager with permission to carry out tokenized investment businesses.
https://masterisegroup.com/en
www.lgt.com
